alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Customer Service Hotline: 1-800-438-2474

UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

REGION III

1650 Arch Street

Philadelphia, Pennsylvania 19103-2029

August 29, 2009

Mr. John Hanger, Secretary

Department of Environmental Protection

Rachel Carson State Office Building

P.O. Box 2063

Harrisburg, PA 17105-2063

Dear Secretary Hanger:

On March 11, 2009, U.S. Environmental Protection Agency (EPA) received a revision to 

the Pennsylvania State Implementation Plan (SIP) from the Department of Environmental 

Protection pertaining to amendments to Subchapters B and C of Chapter 130 of 25 PaCode

submitted by your March 4, 2009 letter. EPA has determined that the submittal is 

administratively and technically complete, and is reviewing it to prepare a (Notice of Proposed 

Rulemaking (NPR). 

If members of your staff have any questions, they may direct them to Christopher Cripps, 

Air Quality Planning Branch, at (215) 814-2179. He is the principal contact for this rulemaking. 

 

Sincerely, 

 /s/

 Diana Esher, Acting Director

 Air Protection Division 

cc: Joyce Epps, PA-DEP
<PAGE>   1
                                                                     EXHIBIT 5.1

                [STRADLLING, YOCCA, CARLSON & RAUTH LETTERHEAD]

                                November 14, 1996

Gish Biomedical, Inc.
2681 Kelvin Avenue
Irvine, California  92714

                  RE:      Registration Statement on Form S-3

Gentlemen:

         At your request, we have examined the form of Registration Statement on
Form S-3 (the "Registration Statement"), being filed by Gish Biomedical, Inc., a
California corporation (the "Company"), with the Securities and Exchange
Commission on November 15, 1996, in connection with the registration under the
Securities Act of 1933, as amended, of 240,240 shares of Common Stock, no par
value, of the Company (the "Common Stock"). The shares of Common Stock may be
offered for resale from time to time by and for the account of the stockholder
of the Company named in the Registration Statement.

         We have reviewed the corporate action of the Company in connection with
this matter and have examined such documents, corporate records and other
instruments as we have deemed necessary for the purposes of this opinion. Based
upon the foregoing and such issues of law as we deem relevant, it is our opinion
that the 240,240 shares of Common Stock covered by the Registration Statement
have been duly authorized and validly issued, and are fully paid and
nonassessable.

         We consent to the use of this opinion as an exhibit to the Registration
Statement and to the use of our name under the caption "Legal Matters" in the
Prospectus, which is a part of the Registration Statement, and any amendment
thereto.

                                          Respectfully Submitted,

                                          STRADLING, YOCCA, CARLSON & RAUTH
Exhibit 10.1

 

SECOND AMENDMENT TO THE

UNITED THERAPEUTICS CORPORATION

SHARE TRACKING AWARDS PLAN

 

WHEREAS, United Therapeutics Corporation (the “Corporation”) maintains the United Therapeutics Corporation Share Tracking Awards Plan, which became effective as June 1, 2008, and was amended on September 14, 2009 (the “Plan”); and

 

WHEREAS, the Board of Directors of the Corporation has the authority under Section 10.1 of the Plan to amend the Plan at any time.

 

NOW, THEREFORE, Article 5 of the Plan is hereby amended to add Section 5.6, which shall read as follows:

 

5.6.         No Future Share Tracking Awards.  Notwithstanding any provision of this Plan to the contrary, including Section 5.1, there shall be no further Awards issued under this Plan after February 1, 2012 (provided that outstanding Awards shall remain subject to adjustment pursuant to Article 7 hereof).  For the avoidance of doubt, any Awards granted prior to February 1, 2012 which thereafter expire, are cancelled, are forfeited or are otherwise terminated unexercised, shall not be available for future Awards hereunder.

 

This Second Amendment to the Plan shall become effective upon its adoption by the Board of Directors of the Corporation.
* Pursuant to Local Rule 47.5, the court has determined

that this opinion should not be published and is not precedent except under the limited circumstances set forth in Local Rule 47.5.4. IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 96-20188 Conference Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus LEONARD NEAL JACKSON, Defendant-Appellant.

- - - - - - - - - - Appeal from the United States District Court for the Southern District of Texas USDC No. H-94-CR-182-1

- - - - - - - - - - February 24, 1997 Before SMITH, EMILIO M. GARZA, and PARKER, Circuit Judges. PER CURIAM: * Leonard Neal Jackson appeals from his conviction by guilty plea of bribery of a public official. Jackson contends that the district court erred by denying his motion to withdraw his guilty plea. We have reviewed the record and the briefs of the parties and we find that the district court did not abuse its discretion by denying Jackson’s motion to withdraw his plea. United States v. Carr , 740 F.2d 339, 344 (5th Cir. 1984). Accordingly, we affirm Jackson’s conviction.No. 96-20188 - 2 - AFFIRMED.
II

104TH CONGRESS

2D SESSION S. 1806

To amend the Federal Food, Drug, and Cosmetic Act to clarify that any

dietary supplement that claims to produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a

drug under the Act, and for other purposes.

IN THE SENATE OF THE UNITED STATES

MAY 23, 1996

Mr. D’AMATO (for himself, Mr. DODD, and Mr. FRIST) introduced the following bill; which was read twice and referred to the Committee on Labor

and Human Resources

A BILL

To amend the Federal Food, Drug, and Cosmetic Act to

clarify that any dietary supplement that claims to

produce euphoria, heightened awareness or similar mental or psychological effects shall be treated as a drug

under the Act, and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. DEFINITION OF DRUG.

4 Section 201(g)(1) of the Federal Food, Drug, and

5 Cosmetic Act (21 U.S.C. 321(g)(1)) is amended by adding

6 at the end thereof the following new sentence: ‘‘Notwith7 standing the preceding sentence, a dietary supplement
2

•S 1806 IS

1 shall be considered a drug under clause (C) if the label

2 or labeling of such drug claims or implies that the dietary

3 supplement produces euphoria, heightened awareness, or

4 similar mental or psychological effects.’’.

Æ
EXHIBIT 99.1

           CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED
            PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In connection with the Annual Report of Trimol Group Inc. (the "Company")
on Form 10-KSB for the period ending December 31, 2002, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned Chief Executive Officer of the Company hereby certifies, pursuant to
18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002 that: (1) the Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934, and (2) the information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company as of and for the periods
covered in the Report.

                                            /s/ Alexander M. Gordin
                                            -----------------------------------
                                            Alexander M. Gordin
                                            Chief Executive Officer
                                            TRIMOL GROUP, INC.

April 14, 2003


                                  41
**Exhibit 32.1**

**CERTIFICATION OFCHIEF EXECUTIVE OFFICER PURSUANT TO18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TO SECTION 906OF THE SARBANES-OXLEY ACT OF 2002**

I, Mark R.Goldston, Chairman and Chief Executive Officer of United Online, Inc. (the“Company”), certify, pursuant to 18 U.S.C. Section 1350, as adoptedpursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to myknowledge:

(a)   theQuarterly Report on Form 10-Q of the Company for the quarter ended March 31,2007, as filed with the Securities and Exchange Commission fully complies withthe requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

(b)   the information contained in such reportfairly presents, in all material respects, the financial condition and result ofoperations of the Company.
| Dated: May 3, 2007                |   |
|----------------------------------------|--------|
| /s/ Mark R. Goldston                   |   |
| Mark R. Goldston                       |   |
| *Chairman and Chief Executive Officer* |   |

 

----
Exhibit
32.2




CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002




In
connection with the Quarterly Report of GlobeTrac Inc. (the “Company”) on Form
10-Q for the period ending March 31, 2008 as filed with the Securities and
Exchange Commission on the date hereof (the “Report”), I, John daCosta, Chief
Financial Officer of the Company and a member of the Board of Directors,
certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:




(1)
        The Report fully complies with the requirements of section 13(a) or
      15(d) of the Securities Exchange Act of 1934;
  and




(2)
        The information contained in the Report fairly represents, the
      financial condition and results of operations of the
    Company.


/s/
      John daCostaJohn
      daCosta
                    Chief
      Financial Officer
                      Date:  May 15, 2008
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1757 Introduced in Senate (IS)]

104th CONGRESS
  2d Session
                                S. 1757

 To amend the Developmental Disabilities Assistance and Bill of Rights 
             Act to extend the Act, and for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 14, 1996

 Mr. Frist (for himself and Mr. Harkin) introduced the following bill; 
 which was read twice and referred to the Committee on Labor and Human 
                               Resources

_______________________________________________________________________

                                 A BILL

 
 To amend the Developmental Disabilities Assistance and Bill of Rights 
             Act to extend the Act, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Developmental Disabilities 
Assistance and Bill of Rights Act Amendments of 1996''.

SEC. 2. REAUTHORIZATION OF ALLOTMENTS FOR STATES.

    Section 130 of the Developmental Disabilities Assistance and Bill 
of Rights Act (42 U.S.C. 6030) is amended by striking ``the fiscal 
years 1995 and 1996'' and inserting ``the fiscal years 1995 through 
1999''.

SEC. 3. REAUTHORIZATION OF AUTHORITIES RELATING TO PROTECTION AND 
              ADVOCACY OF INDIVIDUAL RIGHTS.

    Section 143 of the Developmental Disabilities Assistance and Bill 
of Rights Act (42 U.S.C. 6043) is amended by striking ``the fiscal 
years 1995 and 1996'' and inserting ``the fiscal years 1995 through 
1999''.

SEC. 4. REAUTHORIZATION OF AUTHORITIES RELATING TO UNIVERSITY 
              AFFILIATED PROGRAMS.

    Section 156(a) of the Developmental Disabilities Assistance and 
Bill of Rights Act (42 U.S.C. 6066(a)) is amended by striking ``the 
fiscal years 1995 and 1996'' and inserting ``the fiscal years 1995 
through 1999''.

SEC. 5. REAUTHORIZATION OF AUTHORITIES RELATING TO PROJECTS OF NATIONAL 
              SIGNIFICANCE.

    Section 163(a) of the Developmental Disabilities Assistance and 
Bill of Rights Act (42 U.S.C. 6083(a)) is amended by striking ``the 
fiscal years 1995 and 1996'' and inserting ``the fiscal years 1995 
through 1999''.
                                 <all>
```
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 1518 Placed on Calendar Senate (PCS)]

                                                       Calendar No. 306
104th CONGRESS
  2d Session
                                S. 1518

 To eliminate the Board of Tea Experts by prohibiting funding for the 
        Board and by repealing the Tea Importation Act of 1897.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

              January 5 (legislative day, January 3), 1996

  Mr. Brown (for himself and Mr. Reid) introduced the following bill; 
                     which was read the first time

                            January 10, 1996

            Read the second time and placed on the calendar

_______________________________________________________________________

                                 A BILL

 
 To eliminate the Board of Tea Experts by prohibiting funding for the 
        Board and by repealing the Tea Importation Act of 1897.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Federal Tea Tasters Repeal Act of 
1996''.

SEC. 2. PROHIBITION OF FUNDING.

    None of the funds appropriated or made available to the Federal 
Drug Administration shall be used to operate the Board of Tea Experts 
and related activities.

SEC. 3. REPEAL OF TEA IMPORTATION ACT OF 1897.

    The Tea Importation Act (21 U.S.C. 41 et seq.) is repealed.

SEC. 4. EFFECTIVE DATE.

    This Act shall take effect on the date of enactment of this Act.
                                     

                                                       Calendar No. 306

104th CONGRESS

  2d Session

                                S. 1518

_______________________________________________________________________

                                 A BILL

 To eliminate the Board of Tea Experts by prohibiting funding for the 
        Board and by repealing the Tea Importation Act of 1897.

_______________________________________________________________________

                            January 10, 1996

            Read the second time and placed on the calendar
```
II

104TH CONGRESS

2D SESSION S. 1779

To suspend temporarily the duty on Bis (4-amino-3-methylcyclohexyl)-

methane.

IN THE SENATE OF THE UNITED STATES

MAY 20, 1996

Mr. BREAUX introduced the following bill; which was read twice and referred

to the Committee on Finance

A BILL

To suspend temporarily the duty on Bis (4-amino-3-

methylcyclohexyl)-methane.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. BIS (4-AMINO-3-METHYLCYCLOHEXYL)-METH4 ANE.

5 (a) IN GENERAL.—Subchapter II of chapter 99 of

6 the Harmonized Tariff Schedule of the United States is

7 amended by inserting in numerical sequence the following

8 new heading:

‘‘ 9902.30.30 Bis (4-amino-3-

methylcyclohexyl)-methane

(CAS No. 6864–37–5) (provided for in subheading

2921.30.30) ........................... Free No change No change On or before

12/31/99 ’’.
2

•S 1779 IS

1 (b) EFFECTIVE DATE.—The amendment made by

2 subsection (a) applies with respect to goods entered, or

3 withdrawn from warehouse for consumption, on or after

4 the 15th day after the date of the enactment of this Act.

Æ
EXHIBIT 12.3

CERTIFICATION PURSUANT TO
18 U.S.C SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In
connection with the Annual Report of Elbit Vision Systems Ltd. (the Company)
on Form 20-F for the year ended December 31, 2003 as filed with the Securities
and Exchange Commission on the date hereof (the Report), I, Zami Aberman,
Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. section
1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002,
that to my knowledge:

|1.                | the Report
  fully complies with the requirements of section 13(a) of the Securities
  Exchange Act of 1934; and                                        
|----------------- | --------------------------------------------------------------------------------------------------------------------------------------------------------
|                  |                                                                                                                                                         
|2.                | the
  information contained in the Report fairly presents, in all material
  respects, the financial condition and results of operations of the Company.
|                  |                                                                                                                                                         
|                  | /S/ ZAMI
  ABERMAN                                                                                                                                      
|                  | Zami Aberman                                                                                                                                            
|June 29th,
  2004 | Chief
  Executive Officer                                                                                                                               
|                  |                                                                                                                                                         

A signed original of this written statement required by Section 906 has
been provided to the Company and will be retained by the Company and furnished
to the Securities and Exchange Commission or its staff upon request.

90

---

---
```

[Congressional Record Volume 158, Number 123 (Thursday, September 13, 2012)]
[House]
[Page H5932]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

        A LONG-TERM DEBT SOLUTION TO THE COUNTRY'S FISCAL CLIFF

  (Ms. JENKINS asked and was given permission to address the House for 
1 minute and to revise and extend her remarks.)
  Ms. JENKINS. This week, Moody's threatened to downgrade the U.S.' 
credit rating if Washington fails yet again to deal with the long-term 
debt problem. This is not news. We were downgraded last year, but 
instead of acting to fix the problem, this administration racked up a 
$1 trillion deficit for the fourth year in a row, and now we face a 
fiscal cliff that could cause another recession.
  Enough with the short-term fixes, patches, gimmicks, and tricks. They 
only make the problem worse. This country needs a comprehensive budget 
and tax reform. This means a simpler Tax Code that is more fair and 
efficient, and it means fundamental spending reform that will save 
Medicare.
  We have a rare opportunity to put this country back on the right 
track to ensure a more prosperous future for our children. Let's take 
it. It's time to put the American people first.

                          ____________________
```
1

The Honorable Laurie Smith Camp, United States District Judge for the

District of Nebraska.

United States Court of Appeals

FOR THE EIGHTH CIRCUIT

___________

No. 05-2162

___________

United States of America, *

*

Appellee, *

* Appeal from the United States

v. * District Court for the

* District of Nebraska.

Jose Gustavo Rubio, *

* [UNPUBLISHED]

Appellant. *

___________

Submitted: March 28, 2006

Filed: April 5, 2006 

___________

Before WOLLMAN, MURPHY, and COLLOTON, Circuit Judges.

___________

PER CURIAM.

Jose Gustavo Rubio appeals the sentence imposed by the district court1

 after he

pleaded guilty to conspiracy to distribute and possess with intent to distribute 500

grams or more of a methamphetamine mixture, in violation of 21 U.S.C. §§ 841(a)(1),

(b)(1)(A), and 846, and to one count of criminal forfeiture. In a brief filed under

Anders v. California, 386 U.S. 738 (1967), counsel argues that Rubio’s 168-month

prison sentence, imposed upon consideration of an advisory Guidelines imprisonment
-2-

range of 168-210 months, is unreasonable with regard to 18 U.S.C. § 3553(a), and that

Rubio should instead have been sentenced to the 120-month statutory minimum. 

We note that the sentence imposed comports with Rubio’s plea agreement and

the unobjected-to calculations in the presentence report. We have found nothing in

the record to rebut the presumption that the sentence is reasonable. See United States

v. Lincoln, 413 F.3d 716, 717-18 (8th Cir.) (sentence within Guidelines range gives

rise to presumption of reasonableness, which defendant must rebut), cert. denied,

126 S. Ct. 840 (2005). Although Rubio had no prior convictions, the instant offense

involved a large quantity of methamphetamine, and the district court, having

considered the section 3553(a) factors, showed some leniency by sentencing Rubio

at the bottom of the advisory Guidelines range. 

After reviewing the record independently under Penson v. Ohio, 488 U.S. 75

(1988), we have found no nonfrivolous issues. Accordingly, we affirm the judgment

of the district court.

______________________________
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ENACTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002








In
connection with the Quarterly Report of Global Entertainment Holdings,
Inc.  (the "Company") on Form 10-Q for the period ending September 30,
2009 as filed with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Gary Rasmussen,  Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. § 1350, as enacted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, that:





(1)
            The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934;
and





(2)
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.








/s/ Gary Rasmussen


Gary
Rasmussen,


Chairman
and Chief Executive Officer





November
19, 2009